Journal of Addictive Diseases (J ADDICT DIS )

Publisher: American Society of Addiction Medicine

Description

The Journal of Addictive Diseases is jam-packed with discussions of contemporary issues vital to greater understanding and treatment of alcohol and substance abuse. In addition to providing the most current information on addictive diseases available, this important journal is: the only theme-oriented journal in the addictive disease field that focuses on clinical research and treatment, filled with in-depth bibliographies for clinicians' access to additional helpful information, devoted to featuring state-of-the-art research and clinical applications of prominent researchers and leaders in the substance abuse field, an ideal resource for the desks of physicians, psychiatrists, and therapists specializing in addictions and addictions treatment, as well as researchers, clinical experts, and professors interested in the timely topic of alcoholism/substance abuse. This journal, the essential publication for today's addiction professional, is a highly practical resource that will help you stay on top of the scientific issues and the clinical skills necessary for effective practice. It provides an integrated, multi-specialty perspective on clinically relevant research, treatment, and public policy for specialists in addiction medicine. The only theme-oriented journal in the addiction field focusing on clinical research and treatment, the Journal of Addictive Diseases devotes entire issues to the current, most important topics in addiction medicine. Nationally prominent researchers and leaders in the field contribute articles featuring state-of-the-art research and applications. Some of the timely topics covered in past issues of the Journal of Addictive Diseases include: successful strategies in drug abuse epidemiology, methods for decreasing drug dependent persons' risk for AIDS, research on alcoholism from treatment communities, potential addiction of typically abused drugs, the relationship between AIDS and substance abuse, alcohol and drug abuse in affluent sections of society, dual addiction and the problems faced by these addicts, evaluation of drug treatment programs, effects of maternal alcohol and drug abuse on newborn babies.

  • Impact factor
    1.46
  • 5-year impact
    1.57
  • Cited half-life
    7.20
  • Immediacy index
    0.15
  • Eigenfactor
    0.00
  • Article influence
    0.56
  • Website
    Journal of Addictive Diseases website
  • Other titles
    Journal of addictive diseases
  • ISSN
    1055-0887
  • OCLC
    23070745
  • Material type
    Periodical, Internet resource
  • Document type
    Journal / Magazine / Newspaper, Internet Resource

Publications in this journal

  • Journal of Addictive Diseases 04/2014; 33(2):174-175.
  • [Show abstract] [Hide abstract]
    ABSTRACT: No abstract available for this article.
    Journal of Addictive Diseases 10/2010; 14(1):1-3.
  • [Show abstract] [Hide abstract]
    ABSTRACT: No abstract available for this article.
    Journal of Addictive Diseases 10/2008; 10(1):xi-xii.
  • [Show abstract] [Hide abstract]
    ABSTRACT: No abstract available for this article.
    Journal of Addictive Diseases 10/2008; 13(1):119-130.
  • [Show abstract] [Hide abstract]
    ABSTRACT: No abstract available for this article.
    Journal of Addictive Diseases 10/2008; 12(1):123-133.
  • [Show abstract] [Hide abstract]
    ABSTRACT: THe Halikas-Crosby Drug Impairment Rating Scale for Cocaine (HAL DIRS-C) is designed to measure the advers impact of cocaine use upon life functioning over the previous week. The HAL DIRS-C demonstrated excellent split-half and interrater reliability. Internal consistency of the HAL DIRS-C was shown to be high. All items correlated significantly with total score and loaded on a single factor. The HAL DIRS-C correlated significantly with self-reported cocaine use, craving for cocaine, and independent ratings of the severity of addiction. The HAL DIRS-C was found to be sensitive to clinical change across weekly administrations. The scale is brief, east to administer, and both interviewer and client-friendly. our results suggest that the HAL DIRS-C may be useful as a standardized measure of improvement or outcome in clinical research involving the treatment of cocaine abuse.
    Journal of Addictive Diseases 10/2008; 11(2):121-138.
  • [Show abstract] [Hide abstract]
    ABSTRACT: One difficulty for methadone maintenance treatment programs is the absence of a simple, analytical method useful for guiding adjustment of methadone dose. Currently, dose adjustment decisions are based upon: documentation of continuing opioid use by qualitative urine drug screens, patient complaints of dose not holding or physiological evidence of opioid withdrawal. Although decisions utilizing clinical parameters are helpful in adjustment of dose, a sizeable number of patients continue to receive inadequate doses. Incorrectly, many clinicians assume that low doses prevent toxicity and favor eventual abstinence. One solution to the question of efficacious dose adjustment would be utilization of repetitive blood sampling for monitoring plasma methadone concentrations to insure they remain within established therapeutic windows. Unfortunately, it is impractical to obtain ongoing blood samples from these patients because of poor venous access and the unpleasantness of frequent phlebotomy. To circumvent these problems, we developed analytical methods useful for estimating plasma methadone concentrations from random, spot urine samples. Over the past several years, we have analyzed approximately 16,000 samples (urine plus plasma) drawn from 200 methadone maintenance patients. These data have allowed generation of methadone dose vs. plasma methadone concentration curves, demonstrating why dose adjustment decisions should be buttressed with objective laboratory data. In addition, these methods are useful for uncovering covert methadone supplementation and diversion. These improvements in clinical care have been accomplished using a computerized, pharmacokinetics program which accounts for compounding effects of urine pH, specific gravity, volume of distribution and gender upon renal methadone excretion. The program allows calculation of total plasma methadone concentrations from concurrent urine measurements, which are within 5-10% of actually meausred values. This system has eliminated the need for venous blood sampling, resulted in optimization of patient doses and helped uncover supplementing or diverting of methadone.
    Journal of Addictive Diseases 10/2008; 13(1):5-26.
  • [Show abstract] [Hide abstract]
    ABSTRACT: The purpose of this article is to explore the way in which narcissism is manifest within codependent individuals. Although code-pendent clients present themselves as needy, self-effacing, and overly deferent to others, many of their behavior patterns are actually a manifestation of a subtle form of narcissistic entitlement. Codependents see others as extensions of themselves, rather than as individuals in their own right, and frequently have unrealistic expectations about their relationships. Successful treatment must include an understanding of the developmental underpinnings of their symptoms. Effective psychotherapy also involves maintaining a difficult balance-holding out the expectation of mature adult functioning while simultaneously understanding and accepting clients' initial inability to relate in such a fashion.
    Journal of Addictive Diseases 10/2008; 18(3):55-68.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objective: This study measured the extent and examined implications of hepatitis C (HCV) infection in a methadone maintenance treatment (MMT) population.
    Journal of Addictive Diseases 10/2008; 20(1):19-31.
  • Journal of Addictive Diseases 09/2008; 25(4):139-140.
  • [Show abstract] [Hide abstract]
    ABSTRACT: The use of controlled substances, including opioids, in people who may suffer from concurrent substance use disorders presents challenges to the healthcare professional. Pain and addiction can coexist either as a continuum or separate comorbid conditions. Success in the treatment of either condition requires an approach that encompasses the biopsychosocial needs of the patient. In pain management, controlled substances can be either the problem or the solution, depending on the healthcare professional's training and perspective. Not all patients on opioid pharmacotherapy do well. Some, with inadequate treatment responses, may actually improve on discontinuation of their opioids. Therefore, in any trial of pharmacotherapy, there must be a clear exit strategy as part of the treatment plan. The goal of this article is to explore the importance of making reasoned clinical decisions when faced with aberrant behavior, which is when the patient steps outside the boundaries of the agreed on treatment plan and is established as early as possible in the doctor-patient relationship. In this case, it is essential to separate the "motive" from the "problematic behavior" when trying to interpret the implications of aberrant behavior rather than simply applying a diagnostic label of addiction, which may or may not be correct.
    Journal of Addictive Diseases 02/2008; 27(3):23-30.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Hepatitis C (HCV) infection in substance addicted patients is common and represents a therapeutically challenging co-morbidity. Alcohol and perhaps other substances of abuse directly influence the natural progression of HCV disease. Concurrent mental health illness, poor socioeconomic status, and unstructured life styles are often incompatible with safe and successful delivery of HCV treatment. These issues and their effect on treatment suitability and outcome are considered in this review. Funding for HCV-addiction research and strong political backing for interventions proven to benefit those struggling with addiction are paramount to increasing access to and uptake of HCV treatment. These interventions include substance cessation programs, safe injection settings to reduce HCV incidence and multidisciplinary teams to facilitate HCV treatment provision.
    Journal of Addictive Diseases 02/2008; 27(2):61-8.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Inflated rates of opioid addiction among anesthesiologists may be caused by chronic exposure to low doses of aerosolized anesthetic/analgesic agents in the operating room. Such secondhand exposure produces neurobiological sensitization to the reinforcing effects of these substances, making later addiction more likely. This article extends findings that fentanyl and propofol are detectable in the air of the operating room and demonstrates that fentanyl is also detectable on surfaces in the operating room. Secondhand exposure could, therefore, occur by inhalation and skin absorption. Additionally, data show that many physicians with opiate addiction have a family history of addiction, suggesting genetic vulnerability to the effects of secondhand exposure. Other new data demonstrate that the rates of marijuana and tobacco smoking are much higher among opioid-addicted physicians, suggesting that prior exposure to THC (the psychoactive component of cannabis) or nicotine might increase vulnerability to secondhand effects. Suggestions for reducing secondhand exposure in the operating room are discussed.
    Journal of Addictive Diseases 02/2008; 27(3):67-76.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Coricidin HBP, a cold medication containing dextromethorphan, has become a popular agent abused among adolescents. This retrospective chart review examines the potential psychiatric manifestations of Coricidin HBP misuse and patterns of use among patients treated in an inpatient child and adolescent psychiatric unit. Coricidin HBP use was documented in 47 patient. The data revealed that Coricidin HBP use was associated with: (a) predominantly depressive symptomatology; (b) transient substance-induced psychosis; (c) cardiac toxicity; and (d) greater quantities used per episode by Caucasians. Clinicians treating adolescents need to be aware of the abuse potential and psychiatric manifestations of this dextromethorphan-containing product.
    Journal of Addictive Diseases 02/2008; 27(1):25-32.
  • [Show abstract] [Hide abstract]
    ABSTRACT: AIMS: To establish the personality traits and disorders of pathological gamblers in treatment by means of a descriptive cross-sectional study of two prospective matched-pair cohorts: 50 pathological gamblers versus a control group of 50 normal volunteers (non-patient and non-pathological gamblers). All the pathological gamblers of the sample followed treatment as out-patients in the province of Valencia (Spain-EU). Recruitment period: January-May 2004. MEASURE INSTRUMENTS: South Oaks Gambling Screen, Barratt Impulsivity Scale, Sensation Seeking Scale, and Structured Clinical Interview for Personality Disorders of Axis II of DSM-IV. FINDINGS AND CONCLUSIONS: Male pathological gamblers go more often to health and social care facilities. Pathological gamblers prefer to play slot machines, present a higher prevalence of personality disorders, most of them belonging to cluster B, are more impulsive and higher sensation seekers than the controls. There are no linear relationships between the severity of pathological gambling and the traits of impulsivity and sensation seeking respectively.
    Journal of Addictive Diseases 02/2008; 27(1):33-40.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Opioids have been used for centuries to treat a variety of psychiatric conditions with much success. The so-called "opium cure" lost popularity in the early 1950s with the development of non-addictive tricyclic antidepressants and monoamine oxidase inhibitors. Nonetheless, recent literature supports the potent role of methadone, buprenorphine, tramadol, morphine, and other opioids as effective, durable, and rapid therapeutic agents for anxiety and depression. This article reviews the medical literature on the treatment of psychiatric disorders with opioids (notably, methadone and buprenorphine) in both the non-opioid-dependent population and in the opioid-dependent methadone maintenance population. The most recent neurotransmitter theories on the origin of depression and anxiety will be reviewed, including current information on the role of serotonin, N-Methyl d-Aspartate, glutamate, cortisol, catecholamine, and dopamine in psychiatric disorders. The observation that methadone maintenance patients with co-existing psychiatric morbidity (so called dual diagnosis patients) require substantially higher methadone dosages by between 20% and 50% will be explored and qualified. The role of methadone and other opioids as beneficial psychiatric medications that are independent of their drug abuse mitigating properties will be discussed. The mechanisms by which methadone and other opioids can favorably modulate the neurotransmitter systems controlling mood will also be discussed.
    Journal of Addictive Diseases 02/2008; 27(3):49-65.
  • [Show abstract] [Hide abstract]
    ABSTRACT: New drug therapies to treat hepatitis C (HCV) and HIV infection are being developed with improved understanding of the molecular structures of the viruses themselves, the pathogenesis of infection and the specific immune responses needed to eradicate or control these infections. Interferon and ribavirin based therapies will continue to be a component of HCV therapy for the near future combined with other novel compounds directed at targets of viral replication, immunomodulation or cell entry. The goals of anti-HCV therapy are viral eradication for differing genotypes and prevention of hepatic morbidity such as hepatocellular carcinoma and cirrhosis. Future antiretroviral therapies for HIV will include agents that focus on new classes of inhibitors of viral replication and cell binding. The new treatment choices in HIV will need to ensure effective and durable viral suppression especially against highly resistant virus strains, regimen tolerability and improved toxicity.
    Journal of Addictive Diseases 02/2008; 27(2):83-91.
  • [Show abstract] [Hide abstract]
    ABSTRACT: The current study examined mental health clinician attitudes regarding smoking cessation for psychiatric and substance abusing patients. Participants included n = 15 never smokers, n = 12 former smokers, and n = 7 current smokers. There was a trend (p = 0.08) for current smokers as compared to former and never smokers to be less likely to encourage their clients to stop smoking. Overall, clinicians strongly agreed that an individual's motivation is the most important determinant of success in quitting. Clinicians were concerned that smoking cessation would initiate a relapse to substance abuse. We suggest that mental health clinicians can be instrumental in providing information, encouragement, and opportunities for their patients to attempt smoking cessation.
    Journal of Addictive Diseases 02/2008; 27(1):55-63.